Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 100.00% is 662% above its 1-year average of -17.80%, near the high end of its 1-year range (-189.00%–100.00%).
661.80% above its 12-month average of -17.80%.
Reported quarterly gross margin; no daily interpolation. Q4 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
100.00%
GROSS MARGIN AVG TTM
-17.80%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
54.99%
GROSS MARGIN AVG 15Y
63.82%
GROSS MARGIN AVG 20Y
58.43%
CURRENT VS TTM AVG
+661.80%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+81.84%
CURRENT VS 15Y AVG
+56.70%
CURRENT VS 20Y AVG
+71.14%
SECTOR MEDIAN · HEALTHCARE
40.44%
median of 813 covered companies
CURRENT VS SECTOR MEDIAN
+147.28%
vs the sector median at left
Market Cap
$67.77M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$67.93M
Gross Margin
62.53%
TTM Avg
65.36%
3Y Avg
65.75%
5Y Avg
64.06%
Market Cap
$69.19M
Gross Margin
100.00%
TTM Avg
-0.84%
3Y Avg
37.19%
5Y Avg
-61.56%
Market Cap
$69.78M
Gross Margin
60.78%
TTM Avg
57.02%
3Y Avg
54.79%
5Y Avg
56.72%
Market Cap
$70.16M
Gross Margin
49.30%
TTM Avg
49.08%
3Y Avg
46.18%
5Y Avg
47.39%
Market Cap
$64.41M
Gross Margin
99.56%
TTM Avg
98.97%
3Y Avg
49.48%
5Y Avg
32.99%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iBio, Inc. (IBIO) | $67.52M | 100.00% | -17.80% | 0.00% | 0.00% |
| Tiziana Life Sciences Ltd (TLSA)vs › | $67.77M | 0.00% | 0.00% | 0.00% | 0.00% |
| Fortress Biotech, Inc. (FBIO)vs › | $67.93M | 62.53% | 65.36% | 65.75% | 64.06% |
| XBiotech Inc. (XBIT)vs › | $66.07M | 0.00% | 0.00% | 20.94% | 28.94% |
| Spero Therapeutics, Inc. (SPRO)vs › | $69.19M | 100.00% | -0.84% | 37.19% | -61.56% |
| MindWalk Holdings Corp. (HYFT)vs › | $69.78M | 60.78% | 57.02% | 54.79% | 56.72% |
| Cingulate Inc. (CING)vs › | $64.92M | 0.00% | 0.00% | 0.00% | 0.00% |
| Champions Oncology, Inc. (CSBR)vs › | $70.16M | 49.30% | 49.08% | 46.18% | 47.39% |
| Gossamer Bio, Inc. (GOSS)vs › | $64.41M | 99.56% | 98.97% | 49.48% | 32.99% |
| Heron Therapeutics, Inc. (HRTX)vs › | $64.35M | 70.07% | 73.26% | 61.08% | 58.36% |
Gross Margin
100.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | -189.00% |
| 2025-06-30 | 100.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 100.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | -60.57% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | -400.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 75.41% |
| 2022-03-31 | 100.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | -864.29% |
| 2021-06-30 | 61.91% |
| 2021-03-31 | 35.56% |
| 2020-12-31 | 70.07% |
| 2020-09-30 | 73.90% |
| 2020-06-30 | 23.04% |
| 2020-03-31 | 10.42% |
| 2019-12-31 | 100.00% |
| 2019-09-30 | 100.00% |
| 2019-06-30 | 100.00% |
| 2019-03-31 | 100.00% |
| 2018-12-31 | 100.00% |
| 2018-09-30 | 100.00% |
| 2018-06-30 | 100.00% |
| 2018-03-31 | 100.00% |
| 2017-12-31 | 100.00% |
| 2017-09-30 | 100.00% |
| 2017-06-30 | 100.00% |
| 2017-03-31 | 100.00% |
| 2016-12-31 | 100.00% |
| 2016-09-30 | 100.00% |
| 2016-06-30 | 100.00% |
| 2016-03-31 | 100.00% |
| 2015-12-31 | 100.00% |
| 2015-09-30 | 100.00% |
| 2015-06-30 | 100.00% |
| 2015-03-31 | 100.00% |
| 2014-12-31 | 100.00% |
| 2014-09-30 | 100.00% |
| 2014-06-30 | 100.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 211.57% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 100.00% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 97.28% |
| 2009-03-31 | 49.10% |
| 2008-12-31 | 48.55% |
| 2008-09-30 | 59.32% |
| 2008-06-30 | 58.48% |
| 2008-03-31 | 48.18% |
| 2007-12-31 | 52.60% |
| 2007-09-30 | 50.75% |
